News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Novotech To Discuss Benefits To U.S. Biotech And Pharma Companies Conducting Clinical Trials In Australia This Week At Boston Biorelationships 2004


10/19/2005 5:11:33 PM

Novotech CEO Alek Safarian will discuss the benefits to U.S. biotech and pharmaceutical companies conducting clinical trial research in Australia at this week's Biorelationships 2004 conference in Cambridge, MA. Safarian will discuss the independent contract research organization's work over the past three years with more than 15 U.S.-based pharmaceutical and biotech companies as well as many major European pharmas.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES